"Hopefully, we aren't too far off finding out what's next for the company." I am a bit of a dreamer coads so I am hoping that what's next for the company is that one of the majors will make a substantial offer to buy the rights to first refusal for DurAVR following FDA approval. That would provide non-dilutive funding to complete the trials and still allow a competitive bidding for the final rights. It would also keep the outstanding team together and allow the company to continue it's "structural heart" vision. Just dreaming. Anyone else got any ideas?
AVR Price at posting:
$20.90 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)